Compare InMode Ltd (INMD) vs iShares MBS ETF (MBB) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
InMode Ltd vs iShares MBS ETF — how do they compare? InMode Ltd trades at $14.21 (market cap $809.93M), while iShares MBS ETF trades at $89.79 (market cap $35.41B). The key difference: iShares MBS ETF is far larger — about 43.7× InMode Ltd's market cap, and InMode Ltd is trading nearer its 52-week high, iShares MBS ETF nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold InMode Ltd for 28 Days and iShares MBS ETF for 96 Days on average.
| INMD | MBB | |
|---|---|---|
Market Cap | $809.93M | $35.41B |
Volume | 365,490 | 5,388,525 |
Sector | Health | Fixed Income |
52-Week High | $16.62 | $96.91 |
52-Week Low | $12.76 | $89.09 |
Typical Hold Time | 28 Days | 96 Days |
Enterprise Value | $313.27M | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
InMode (INMD) trades at $14.21, up 1.43% with mixed technical signals showing bearish moving averages but neutral oscillators. The company maintains strong fundamentals with a P/E of 11.63, gross margins of 76.52%, and consistent profitability. Recent Q2 2026 earnings beat expectations with $95.6M revenue, while facing shareholder activism from Steel Partners' $16.75 per share acquisition offer.
Investment outlook remains cautious with analyst consensus divided (45% Buy, 55% Hold) amid cyclical industry softness. Key opportunities include international growth and new product launches like Morpheus8 Cool, while risks involve US sales declines and capital allocation concerns. The stock presents value characteristics but requires monitoring of management's strategic response to acquisition pressure.
MBB (iShares MBS ETF) trades at $89.79, up 0.64% with bearish technical signals from moving averages and ADX indicators. The ETF faces headwinds from rising intermediate-term rates and inflation pressures, with short interest surging 98.3% in September. Recent institutional buying by Corient Private Wealth and Baird Financial contrasts with technical weakness and negative analyst commentary on duration risk.
Outlook remains cautious due to interest rate sensitivity and convexity risks in mortgage-backed securities. The 5.68-year effective duration exposes MBB to Fed policy shifts, though Norway's $2.3 trillion sovereign fund rotation into MBS provides counterbalancing institutional support. Key risks include prepayment optionality and persistent inflation eroding real returns.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About InMode Ltd
InMode provides innovative medical technologies for minimally invasive surgical procedures. Its platforms use radiofrequency (RF) energy for aesthetic treatments like body contouring and skin tightening.
Read more on INMD →About iShares MBS ETF
The fund will invest at least 80% of its assets in the component securities of the underlying index and TBAs that have economic characteristics that are substantially identical to the economic characteristics of the component securities of the index, and the fund will invest at least 90% of its assets in fixed income securities included in the underlying index that advisor believes will help the fund track the index.
Read more on MBB →
